Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia | MicrobiomeTrials← Back to trialsNCT05753748
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-01-24Est. Completion: 2029-04-30
Enrollment target: 680 participants Locations- University of California, Los Angeles, Los Angeles, California, United States
- Kaiser Permanente Oakland Medical Center, Oakland, California, United States
- Kaiser Permanente, San Jose, California, United States
- University of Colorado, Aurora, Colorado, United States
- Florida Digestive Health Specialists, Sarasota, Florida, United States
- Northwestern Memorial Hospital, Chicago, Illinois, United States
- Indiana University Melvin & Bren Simon Cancer Center, Indianapolis, Indiana, United States
- Johns Hopkins Universtiy, Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
- Long Island Jewish Medical Center, Manhasset, New York, United States
- Columbia Universtiy, New York, New York, United States
- University of Rochester Medical Center, Rochester, New York, United States
Other microbiome trials you might be interested in
Cancer RiskCancer Predisposition SyndromeHereditary Cancer PredictionChildhood Cancer SurvivorsAdult Cancer SurvivorsIARC CarcinogensSmoking HistoryLung CancerDuctal/Lobular CarcinomaBarrett EsophagusPancreatic Precursor LesionsColonic Dysplasia/AdenomataNon-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisCirrhosisHigh Grade Prostatic Epithelial NeoplasiaHigh-grade Bladder Urothelial Dysplasia/Carcinoma in SituAdenomatous Hyperplasia
University of North Carolina School of Medicine, Chapel Hill, North Carolina, United StatesUniversity Hospitals Cleveland Medical Center Case Western University, Cleveland, Ohio, United StatesCleveland Clinic Foundation, Cleveland, Ohio, United StatesUniversity of Pennsylania, Perelman School of Medicine, Philadelphia, Pennsylvania, United StatesUniversity of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United StatesMedical University of South Carolina, Charleston, South Carolina, United StatesBaylor University Medical Center, Dallas, Texas, United StatesThe University of Texas MD Anderson Cancer Center, Houston, Texas, United StatesHigh-risk Oral Precancerous Diseases
Melanocytic Lesion, Adult
Hematologic Malignancy
Lung; Node
Serous Tubal Intraepithelial Carcinoma
Endometrial Intraepithelial Neoplasia
Cervical and Endocervical Carcinoma in Situ
Vulvar Intraepithelial Neoplasia
Nephrogenic Rests
Benign Bone Lesions With Risk of Malignant Degeneration
Giant Cell Tumor
Osteochondroma
Spitz Nevus
This research study is creating a way to collect and store specimens and information from participants who may be at an …
Boston, United StatesEst. completion Mar 25, 2030
Barrett's Esophagus (BE)
Prospective, open-label, single-arm, early feasibility study (EFS) in 2 Patient cohorts: Cohort A - Dose finding / Dose …
Brno, CzechiaEst. completion Dec 31, 2026